Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan vs Ultrafiltration in Acute Decompensated Heart Failure
NCT01863511Phase 4Completed
- Sponsor
- The Christ Hospital
- Start
- May 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tolvaptan in heart failure (HF) (3 arms), sponsored by The Christ Hospital. Primary endpoint: Net change in weight at Day 5. Started May 2013; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01863511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863511.